We have examined the functional significance of the naturally occurring mutation at position 64 of human b3-adrenergic receptor (b3AR), which changes the amino acid from tryptophan to arginine (W64R-b3AR). The affinities of b AR agonists for W64R-b 3AR expressed in COS-7 cells were not significantly different from those for wild type b3AR. When two receptors are expressed at various expression levels, and stimulated with CGP12177A, they showed essentially the same EC50 values and maximal responses. Overexpression of Gi and Go, or the treatment with pertussis toxin did not affect the agonistinduced cAMP response, suggesting that Gi and Go did not contribute to the b3AR-induced cAMP response. However, the enhanced cAMP response was observed when W64R-b3AR was coexpressed with the adenylyl cyclase type III isoform, and stimulated by CGP12177A and isoproterenol. These results indicate that the cAMP response of W64R-b3AR can be enhanced under the particular condition that adenylyl cyclase type III was coexpressed.
The b3-adrenergic receptor (b3AR) belongs to a superfamily of G protein-coupled receptors and is mainly expressed in adipose tissue and the gastrointestinal tract (1) . Stimulation of b3AR activates adenylyl cyclase (AC) and increases the intracellular concentration of cAMP, leading to lipolysis and thermogenesis. b 3 AR agonists are envisioned as one of the anti-obesity drugs (2) .
Three groups independently reported that the mutation of tryptophan to arginine at position 64 of human b 3 AR (W64R-b 3 AR) correlates with obesity, glucose intolerance, hypertension, dyslipidemia and early onset of non-insulindependent diabetes mellitus (3 -5) . However, the functional significance of the mutation remains an unsolved issue. Candelore et al. have examined ligand binding, activation of AC and desensitization pattern, and they found that the biochemical characteristics of W64R-b 3 AR are essentially the same as those of wild type (WT)-b 3AR (6) . In contrast to their report, Pietri-Rouxel et al. reported that the degree of maximal cAMP response by W64R-b 3 AR stimulation is lower than that by WT-b 3AR stimulation (7) . They also showed that the ligand binding characteristics of agonists and antagonists for W64R-b3AR and the half maximal concentrations of agonists to activate W64R-b 3 AR are same as those of WT-b3AR (7) . There is a difference in assay system between the two groups: one group used a pool of cells that showed resistance to antibiotics, and the other group used clonal cell lines that stably expressed receptors. Thus, it remains to be determined whether W64R-b 3 AR has a decreased or increased ability to induce the cAMP response. Granneman reported that the AC type III isoform (AC-III) is selectively increased in brown adipose tissue by neural stimulation or by cold exposure (8) . Therefore, it is also necessary to compare the b 3 ARmediated responses under the condition that the expression of AC-III is increased. In the present study, we report that W64R-b 3 AR shows an enhanced cAMP response compared with WT-b3AR, when W64R-b3AR is coexpressed with AC-III. . Sources of other reagents were mentioned in the previous report (9) .
MATERIALS AND METHODS

Materials
Construction and expression of WT-b 3AR and mutant b3AR
Human WT-b 3 AR gene was cloned from HeLa genomic DNA by the polymerase chain reaction (PCR), and the second exon containing 6 amino acids at the carboxyl terminus was introduced by PCR as described (10) . The mutation at position 64 (arginine instead of tryptophan) was introduced by PCR. The entire coding regions of WTand W64R-b 3 ARs were inserted into expression vector pEF-BOS (11) . These two b3AR constructs were used for transfection into COS-7 cells or JEG-3 cells by the DEAE-dextran method as described (12) . Cells were plated onto a 100-mm dish for transfection. When b 3AR was cotransfected with Go or AC isoform, 1 mg of G=o in pcDNA3 together with G >1 in pCMV5, G C2 in pCMV5 and 5 mg of AC-I, -II, -III or -VI were used.
Radioligand binding assay
The crude membrane fraction from the transfected cells was prepared as described (9) . Approximately 10 m g of membrane protein was used for radioligand binding studies, and 50 pM [ 125 I]ICYP was used for competition binding assays. Nonspecific binding was determined in the presence of 1 mM CGP12177A.
Determination of cAMP content in COS-7 and JEG-3 cells
The transfected COS-7 and JEG-3 cells were split into 6-well plates and incubated overnight (37°C, 5% CO 2 ) in culture medium containing 1 mCi /ml [ 3 H]adenine. The cells were stimulated in DMEM medium containing 20 mM HEPES (pH 7.4), 1 mM 3-isobutyl-1-methyxanthine and the various concentrations of agonists for 15 min at 37°C. The reaction was stopped, and generated [ 3 H]cAMP was iso-lated as described (12) . The cAMP production was calculated as the ratio of [ 3 H]cAMP to total [ 3 H]nucleotides per well (cAMP%/well) or normalized as fold stimulation, setting cAMP content without agonist as 1.0.
Data analyses
All data shown are mean values ± S.E.M. from three or four independent experiments. Equilibrium dissociation constants were determined from saturation isotherms, and competition curves were analyzed by a non-linear regression analysis using PRISM software (GraphPAD Software Inc., San Diego, CA, USA). The statistical significance was assessed with the t test or Dunnett's test.
RESULTS
Ligand binding characteristics
The affinities of various drugs for WT-or W64R-b3ARs were determined by ligand binding assay. The dissociation constant (K d ) of ICYP for W64R-b 3 AR was similar to the value of WT-b3AR (Table 1 ). Table 1 also shows that Ki values of the various agonists for W64R-b3AR are essentially the same as those for WT-b 3 AR. Thus, pharmacological characteristics of W64R-b3AR are similar to those of WT-b 3AR.
Basal and receptor-stimulated cAMP responses
As CGP12177A is a partial agonist for b3AR and an antagonist for b 1 -and b 2 ARs, COS-7 cells did not respond to CGP12177A stimulation when the cells were not transfected with b 3AR (Fig. 1 ). Stimulation by CGP12177A increased cAMP content in a dose-dependent manner in WT-and W64R-b 3AR-expressing cells, and the EC50 value of CGP12177A to induce cAMP response of W64R-b3AR was essentially the same as that of WT-b 3 AR ( Fig. 1 ). As the basal and agonist-stimulated cAMP accumulation is related to the expression level of the receptor, we determined the basal and CGP12177A-stmulated cAMP responses of WT-and W64R-b3ARs at the various expression levels. Figure 2 shows that the basal and CGP12177Astimulated cAMP responses for two receptors are gradually increased by the increasing level of expression. The cAMP responses with or without CGP12177A were essentially the same between two b 3 ARs. This result indicates that W64R-b 3AR activates Gs in similar potency and efficacy to WT-b3AR.
To examine the involvement of Gi and Go in the CGP12177A-stimulated cAMP accumulation, we determined the role of Gi and Go in the basal and CGP12177Astimulated cAMP accumulation. To amplify the Gi-and G o -mediated signal, we expressed b 3 AR together with G i (expressed as a i2 · b 1 · g2) or Go (expressed as a o · b1 · g2). In Gi-over-expressing cells, the basal and CGP12177Astimulated cAMP responses by W64R-b 3 AR stimulation were essentially the same as those by WT-b3AR stimulation. Pertussis toxin (PTX) treatment did not affect the basal and CGP12177A-stimulated cAMP responses (Fig. 3) . When COS-7 cells were not transfected with b3AR, CGP12177A stimulation did not increase cAMP accumulation in the PTX-treated cells. This result indicates that PTX treatment itself does not affect the level or function of components involved in the b3AR /Gs/AC system. The treatment of W64R-b3AR and Gi-but not Go-over-expressing cells with PTX slightly but not significantly enhanced the cAMP response induced by CGP12177A stimulation (Fig. 4) . 
AC co-transfection
As neural stimulation of and cold exposure to brown adipose tissue selectively increases the expression of AC-III among AC-III, IV, V and VI (8), we examined the CGP12177A-induced cAMP response in cells expressing WT-or W64R-b 3 ARs under this particular condition. Therefore, WT-and W64R-b3ARs were co-expressed with AC-I, -II, -III or -VI in JEG-3 cells. As COS-7 but not JEG-3 cells express endogenous bAR, JEG-3 cells were used for stimulation by the full agonist isoproterenol. When W64R-b 3AR was coexpressed with AC-III and AC-VI, CGP12177A stimulation enhanced the cAMP response as compared to WT-b 3 AR co-expressing with AC-III and AC-VI (Fig. 5A) . When W64R-b3AR was stimulated by isoproterenol, the cAMP response was enhanced in AC-III-expressing cells (Fig. 5B ). Co-transfection of AC-VI slightly but not significantly enhanced the isoproterenolinduced increase in cAMP accumulation. These results indicate that co-expression of W64R-b 3 AR with AC-III enhances the agonist-induced cAMP response as compared to co-expression of WT-b 3AR with AC-III.
DISCUSSION
It has been reported that the mutation of tryptophan to arginine at position 64 of human b 3 AR is associated with obesity, glucose intolerance, hypertension, dyslipidemia and early onset of non-insulin-dependent diabetes mellitus (2) . However, two groups reported different results of biochemical characterization of mutated b3AR (W64R-b3AR). Pietri-Rouxel et al. reported the decreased ability of W64R-b 3 AR to maximally activate AC (7) . In contrast to their report, Candelore et al. did not observe any significant differences between WT-and W64R-b 3AR (6) . In the present study, we compared the biochemical and pharmacological characteristics of W64R-b3AR to those of WT-b3AR. We used a transient assay system to avoid clonal variation of receptor-expressing cells. The binding experiments showed that the affinities of various agonists for W64R-b 3AR were essentially the same as that of WTb 3 AR. This result is consistent with those of the previous reports.
Basal and CGP12177A-stimulated cAMP responses of W64R-b 3AR were almost the same as those of WT-b3AR. As the receptor-stimulated cAMP response is affected by the expression level of receptors, we determined the responses at various expression levels of the two b 3ARs. We did not observe significant differences of basal and CGP12177A-induced cAMP responses between W64Rand WT-b 3ARs. This result supports the conclusion of Candelore et al. (6) , in which they did not detect any significant biochemical and pharmacological differences between the two receptors. Several groups reported that b3AR interacts not only with G s but also with G i (13 -15) and found that b3AR activates extracellular receptor-regulated kinase in a Gi-dependent manner (13, 14) . Gauthier et al. reported that G i is involved in b 3 AR-mediated signaling in the heart (15) . Therefore, we examined whether the functional contribution of Gi and Go explains the decreased ability of W64R-b 3 AR to increase cAMP content. PTX treatment did not affect WT-and W64R-b3AR-induced cAMP responses even under the condition that Gi and Go were over-expressed in a heterotrimeric form. This result suggests that coupling of two b 3 ARs with G i and G o did not contribute to the cAMP response in COS-7 cells. Although we could not observe any functional differences between the two b 3 ARs, we have found a difference between WTand W64R-b3AR-mediated cAMP responses under a particular condition. Granneman demonstrated that rat brown adipose tissue expresses four kinds of AC isoforms, and the level of mRNA for AC-III is selectively increased by stimulation of the sympathetic nervous system (8) . When AC-III was co-expressed with W64R-b 3 AR, CGP12177Aand isoproterenol-stimulated cAMP responses were significantly enhanced as compared to cAMP response in the cells expressing WT-b 3 AR and AC-III. However, the isoproterenol-stimulated cAMP response in W64R-b3AR co-expressing AC-VI was slightly but not significantly enhanced, in contrast to co-expression with AC-III. CGP12177A is a partial agonist and isoproterenol is a full agonist. AC-VI but not AC-III is phosphorylated by protein kinase A, and the activity is impaired by the phosphorylation. Therefore, it is possible that isoproterenol stimulation slightly decreases AC-VI activity by protein kinase A activation. Although the expression levels of b 3 ARs and AC are important determinansts for the receptor-mediated cAMP response, basal cAMP responses are essentially the same between WT-and W64R-b 3 ARs-expressing cells in AC-III and AC-VI expressing cells. Therefore, it is reasonable to conclude that the expression levels of b3ARs and AC are similar to each other, and the differential expression is not enough to explain the enhanced cAMP response induced by W64R-b 3AR stimulation. Guan et al. demonstrated that third intracellular loop of b 3 AR is a critical region for coupling of b3AR with Gs (16) . Because the mutation at position 64 is located at the first intracellular loop, this amino acid may directly participate in the interaction with G s as previously suggested. As AC-III shows a modestly high turnover number of cAMP synthesis (17), the small increase in coupling efficiency of b3AR of W64R-b 3 AR to G s may become apparent in the presence of AC-III. One of the consequences of the differential cAMP responses of WT-b3AR and W64R-b3AR is downregulation of b 3 ARs. Because downregulation of b 3 AR is dependent on cAMP content (18), W64R-b 3AR may downregulate faster than WT-b 3AR under the condition that AC-III is co-expressed.
In conclusion, the mutated b3AR at position 64 (W64Rb 3AR) did not show any pharmacological and functional differences from WT-> 3 AR. However, W64R-> 3 AR showed the enhanced cAMP response when AC-III is co-expressed together with the receptor. It remains to be determined whether this difference plays a role in regulation of b 3 AR in vivo.
